As a consequence of the decision of the United Kingdom to go its separate way, the remaining European Union member states decided yesterday that the European Medicines Agency should move to Amsterdam by the end of March 2019. Continue reading ->
The Office of the United States Trade Representative (USTR) has issued a set of negotiating objectives for renegotiating the 1994 North American Free Trade Agreement (NAFTA) that include its hopes for elevating intellectual property in the trade deal. Included in the list: force Canada and Mexico to ratify international treaties, accept US law on IP protection and create conditions for “strong” IP enforcement especially online, and ensure ample protection for products with generic names. Perhaps oddly, there is only one mention of trade agreements, which includes respect for a 2001 text at the World Trade Organization on IP and public health. Continue reading ->
Trade ministers negotiating the Trans-Pacific Partnership (TPP) without the United States have dropped many problematic provisions related to intellectual property and health, Médicins Sans Frontières (MSF, Doctors Without Borders) reported today. Also removed from the agreement appears to be the investor-state dispute settlement provisions, according to a source. Continue reading ->
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria today selected Peter Sands, a former bank CEO who is involved in health projects at the World Bank and elsewhere, as its next executive director.Continue reading ->
Days after withdrawing from consideration to be the next director of the Global Fund for AIDS, Tuberculosis and Malaria, the UK’s Peter Sands has asked to be reinstated. The actions come as the Fund’s Board gathers this week to choose among the final candidates for head of the international health funding organisation based in Geneva. Continue reading ->
The World Health Organization is consulting member states and stakeholders on the future of its mechanism to help prepare the world for the next influenza pandemic. It is particularly asking whether countries should submit not only the biological samples of their influenza viruses, but also their genetic information through the mechanism. Also in question is whether the mechanism should be extended to cover seasonal influenza. Stakeholders had different views but all questioned the absence of recognition by the WHO of a widely used database currently hosting most of the world’s influenza genetic information. Continue reading ->
The World Intellectual Property Organization this week held an event that delved into research, markets and access for vaccines with panels that showed unusual breadth of representation for the UN IP agency. But health advocates have taken issue with the wording of a report released by WIPO at the event. Continue reading ->
A well-represented set of experts this week held discussions on the current situation of access to vaccines, the market, the role of pharmaceutical companies, and partnerships. Vaccines were not a field much affected by patents in the past, but the situation has changed and new vaccines are now covered by intellectual property, which might constitute a barrier to access, according to speakers. Continue reading ->
Against the growing threat of a world where bacteria can kill again because they have developed resistance to available antibiotics, and the lack of new promising options in the research pipeline, several international agencies are seeking solutions. The World Health Organization today published a set of recommendations to help stop the routine use of antibiotics to promote growth and prevent disease in healthy animals. Continue reading ->
Hidden amongst the thousands of Facebook pages given over to holiday snaps and gossip are groups of patients who have hepatitis C, a disease that affects more than 70 million worldwide and kills around 400,000 people a year.
But importantly, these groups of patients from Russia to Australia have got together to help each other import a relatively new class of drug that is able to cure most of the patients who take it. Continue reading ->